TrialOncoimmunology2020

Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).

Carl Christoph Schimanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.